TickerFacts.

Incannex Healthcare Inc. (IXHL): Revenue

Annual figures by period end, from SEC filings.

$86.0K
Year ended 2025-06-30
2024-06-30: $12.0K2025-06-30: $86.0K$86.0K
2024-06-30 Revenue (USD) 2025-06-30
Period endedRevenueChange YoYSource filing
2025-06-30$86.0K+616.7%2025-09-29, From 2024-07-01
2024-06-30$12.0Kn/a2025-09-29, From 2023-07-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Incannex Healthcare Inc. (IXHL)2025-06-30$86.0K+616.7%
Actinium Pharmaceuticals, Inc. (ATNM)2025-12-31$90.0Kn/a
iBio, Inc. (IBIO)2026-06-30$100.0K-75.0%
Silo Pharma, Inc. (SILO)2025-12-31$72.1K0.0%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$65.3K-70.0%
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$64.0K-99.8%
BullFrog AI Holdings, Inc. (BFRG)2025-12-31$116.7Kn/a
Avalo Therapeutics, Inc. (AVTX)2025-12-31$59.0K-86.6%
Serina Therapeutics, Inc. (SER)2025-12-31$130.0K+132.1%

Compare IXHL, ATNM, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗